Maccura Biotechnology Co.,Ltd.’s Net Profit Dropped 27.9% in First Three Quarters of 2022
Listen to the full version

Maccura Biotechnology Co.,Ltd. (迈克生物股份有限公司) (300463.SZ) reported a net profit of 600.4 million yuan in the first three quarters of 2022, down 27.9% year-on-year.
Meanwhile, the company posted 2.7 billion yuan in revenue, down 9.7% year-on-year.
At the end of the reporting period, it had 8.2 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 21.4%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR